|
1
|
National Cancer Institute (NCI), . Colon
Cancer Treatment (PDQ®)-Patient Version. NCI; Bethesda,
MD: 2017, https://www.cancer.gov/types/colorectal/patient/colon-treatment-pdqFebruary
27–2017
|
|
2
|
IARC, . World Cancer Report 2014: World
Health Organization. Chapter. 5:52014.
|
|
3
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
4
|
IARC, . World Cancer Report 2014: World
Health Organization. Chapter. 1:12014.
|
|
5
|
Brody H: Colorectal cancer. Nature.
521:S12015. View
Article : Google Scholar
|
|
6
|
Stein A, Atanackovic D and Bokemeyer C:
Current standards and new trends in the primary treatment of
colorectal cancer. Eur J Cancer. 47 Suppl 3:S312–S314. 2011.
View Article : Google Scholar
|
|
7
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
9
|
Wang XJ, Reyes JL, Chua NH and Gaasterland
T: Prediction and identification of Arabidopsis thaliana microRNAs
and their mRNA targets. Genome Biol. 5:R652004. View Article : Google Scholar
|
|
10
|
Mraz M and Pospisilova S: MicroRNAs in
chronic lymphocytic leukemia: From causality to associations and
back. Expert Rev Hematol. 5:579–581. 2012. View Article : Google Scholar
|
|
11
|
Musilova K and Mraz M: MicroRNAs in B cell
lymphomas: How a complex biology gets more complex. Leukemia.
29:1004–1017. 2015. View Article : Google Scholar
|
|
12
|
Trang P, Weidhaas JB and Slack FJ:
MicroRNAs as potential cancer therapeutics. Oncogene. 27 Suppl
2:S52–S57. 2008. View Article : Google Scholar
|
|
13
|
Li YC, Li CF, Chen LB, Li DD, Yang L, Jin
JP and Zhang B: MicroRNA-766 targeting regulation of SOX6
expression promoted cell proliferation of human colorectal cancer.
Onco Targets Ther. 8:2981–2988. 2015. View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
15
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar
|
|
16
|
Osada H and Takahashi T: MicroRNAs in
biological processes and carcinogenesis. Carcinogenesis. 28:2–12.
2007. View Article : Google Scholar
|
|
17
|
Shen F, Cai WS, Feng Z, Li JL, Chen JW,
Cao J and Xu B: miR-492 contributes to cell proliferation and cell
cycle of human breast cancer cells by suppressing SOX7 expression.
Tumour Biol. 36:1913–1921. 2015. View Article : Google Scholar
|
|
18
|
Zhang Z, Sun J, Bai Z, Li H, He S, Chen R
and Che X: MicroRNA-153 acts as a prognostic marker in gastric
cancer and its role in cell migration and invasion. Onco Targets
Ther. 8:357–364. 2015.
|
|
19
|
Li X, Wang J, Jia Z, Cui Q, Zhang C, Wang
W, Chen P, Ma K and Zhou C: miR-499 regulates cell proliferation
and apoptosis during late-stage cardiac differentiation via Sox6
and cyclin D1. PLoS One. 8:e745042013. View Article : Google Scholar
|
|
20
|
Brandt DT, Baarlink C, Kitzing TM, Kremmer
E, Ivaska J, Nollau P and Grosse R: SCAI acts as a suppressor of
cancer cell invasion through the transcriptional control of
beta1-integrin. Nat Cell Biol. 11:557–568. 2009. View Article : Google Scholar
|
|
21
|
Chen X, Hu W, Xie B, Gao H, Xu C and Chen
J: Downregulation of SCAI enhances glioma cell invasion and stem
cell like phenotype by acti-vating Wnt/β-catenin signaling. Biochem
Biophys Res Commun. 448:206–211. 2014. View Article : Google Scholar
|
|
22
|
Juliano R: SCAI blocks MAL-evolent effects
on cancer cell invasion. Nat Cell Biol. 11:540–542. 2009.
View Article : Google Scholar
|
|
23
|
Turajlic S and Swanton C: Metastasis as an
evolutionary process. Science. 352:169–175. 2016. View Article : Google Scholar
|
|
24
|
Brábek J, Mierke CT, Rösel D, Veselý P and
Fabry B: The role of the tissue microenvironment in the regulation
of cancer cell motility and invasion. Cell Commun Signa. 8:222010.
View Article : Google Scholar
|
|
25
|
Haeger A, Wolf K, Zegers MM and Friedl P:
Collective cell migration: Guidance principles and hierarchies.
Trends Cell Biol. 25:556–566. 2015. View Article : Google Scholar
|
|
26
|
Clark AG and Vignjevic DM: Modes of cancer
cell invasion and the role of the microenvironment. Curr Opin Cell
Biol. 36:13–22. 2015. View Article : Google Scholar
|
|
27
|
Galliera E, Tacchini L and Corsi Romanelli
MM: Matrix metalloproteinases as biomarkers of disease: Updates and
new insights. Clin Chem Lab Med. 53:349–355. 2015. View Article : Google Scholar
|
|
28
|
Cathcart J, Pulkoski-Gross A and Cao J:
Targeting matrix metalloproteinases in cancer: Bringing new life to
old ideas. Genes Dis. 2:26–34. 2015. View Article : Google Scholar
|
|
29
|
Ballard-Barbash R, Friedenreich CM,
Courneya KS, Siddiqi SM, McTiernan A and Alfano CM: Physical
activity, biomarkers, and disease outcomes in cancer survivors: A
systematic review. J Natl Cancer Inst. 104:815–840. 2012.
View Article : Google Scholar
|
|
30
|
Pandurangan AK: Potential targets for
prevention of colorectal cancer: A focus on PI3K/Akt/mTOR and Wnt
pathways. Asian Pac J Cancer Prev. 14:2201–2205. 2013. View Article : Google Scholar
|
